Cat-PAD Follow on Study

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Cat AllergyRhinoconjunctivitis
Interventions
BIOLOGICAL

Placebo

No further medication to be administered in this study. Intervention refers to treatment received in Study CP005.

BIOLOGICAL

Cat-PAD Dose 1

No further medication to be administered in this study. Intervention refers to treatment received in Study CP005.

BIOLOGICAL

Cat-PAD Dose 2

No further medication to be administered in this study. Intervention refers to treatment received in Study CP005.

Trial Locations (1)

Unknown

Cetero Research, Mississauga

All Listed Sponsors
collaborator

Cetero Research, San Antonio

NETWORK

collaborator

Adiga Life Sciences, Inc.

INDUSTRY

lead

Circassia Limited

INDUSTRY